Picture of Vitrolife AB logo

VITR Vitrolife AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Annual cashflow statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line460537-3,712674-4,886
Depreciation
Non-Cash Items-30.8804,376675,860
Unusual Items
Other Non-Cash Items
Changes in Working Capital-154-377-332-276-339
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities384636757907635
Capital Expenditures-62.4-87-119-202-270
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-6,456-57-5-175-32
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6,518-144-124-377-302
Financing Cash Flow Items-33.4-12-1-1-10
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5,749-582-300-286-553
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-343-51283273-326